Oncopharmpod
Lorlatinib
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:24:13
- More information
Informações:
Synopsis
Reviewing the latest TKI approved for ALK rearranged metastatic NSCLC. And hey, how 'bout that crazy rifampin hepatotoxicity interaction?